Figure 4 From: Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies Score changes in patient-reported outcome scales. Mean (and standard error) score change in (a) Gastrointestinal Symptom Rating Scale (GSRS) and (b) Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire (pooled intention-to-treat population).Back to article page